The global factor Xa inhibitor market is witnessing significant growth in the coming years. This trend can be attributed to a rising prevalence of blood clotting diseases worldwide, coupled with an senior population. Furthermore, advancements in click here technology have led to the development of more potent factor Xa inhibitors, driving market de